Manulife (Manufacturers Life Insurance)
VERA icon

Manulife (Manufacturers Life Insurance)’s Vera Therapeutics VERA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52M Sell
105,293
-40,896
-28% -$1.52M ﹤0.01% 1231
2026
Q1 		$5.88M Sell
146,189
-61,779
-30% -$2.66M 0.01% 1090
2025
Q4 		$10.6M Buy
207,968
+68,383
+49% +$2.43M 0.01% 842
2025
Q3 		$4.06M Sell
139,585
-279
-0.2% -$6.45K ﹤0.01% 1258
2025
Q2 		$3.3M Sell
139,864
-1,545
-1% -$34.7K ﹤0.01% 1326
2025
Q1 		$3.4M Buy
141,409
+13,029
+10% +$419K ﹤0.01% 1307
2024
Q4 		$5.43M Buy
128,380
+26,519
+26% +$1.17M ﹤0.01% 1170
2024
Q3 		$4.5M Sell
101,861
-176
-0.2% -$6.68K ﹤0.01% 1252
2024
Q2 		$3.69M Buy
102,037
+22,337
+28% +$886K ﹤0.01% 1293
2024
Q1 		$3.44M Buy
79,700
+66,643
+510% +$2.37M ﹤0.01% 1331
2023
Q4 		$201K Sell
13,057
-503
-4% -$6.39K ﹤0.01% 2624
2023
Q3 		$186K Buy
13,560
+17
+0.1% +$292 ﹤0.01% 2637
2023
Q2 		$217K Buy
+13,543
New +$122K ﹤0.01% 2563

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VERA Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Vera Therapeutics (VERA) stake by 28% in Q2 2026, selling an estimated $1.52M and leaving 105,293 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Manulife (Manufacturers Life Insurance) first reported a position in VERA in Q2 2023 and has held it in 13 quarters since. The position peaked at $10.6M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 105,293 shares of Vera Therapeutics worth $4.52M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 40,896 Vera Therapeutics shares in Q2 2026, an estimated $1.52M.
  • Vera Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1231 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Vera Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Vera Therapeutics position peaked at $10.6M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.